Anti-Malaria drug could treat Polycystic Ovary Syndrome, study reveals

Published On 2024-06-20 11:32 GMT   |   Update On 2024-06-20 11:32 GMT
In a study published in the journal Science, the malaria drug artemisinin has shown promise in treating Polycystic Ovary Syndrome (PCOS) symptoms. PCOS disrupts hormone production, causing irregular periods, infertility, and other symptoms. It is often associated with insulin resistance, which can lead to weight gain and worsen the condition.
The study involved a clinical trial with 19 women suffering from PCOS. Researchers found that artemisinin improved menstrual cycle regularity and significantly lowered testosterone levels, a common hormonal imbalance in PCOS. Additionally, most participants saw a decrease in anti-Mullerian hormone levels, another marker for PCOS, and 12 women experienced restored menstrual regularity after three months of treatment.
Advertisement
Reference: Yang Liu et al.,; Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction; Science384,eadk5382(2024).DOI:10.1126/science.adk5382


Full View
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News